Peter Kim serves as Director of Financial Planning & Analyisis of AVEO Oncology, an LG Chem company. With a financial career spanning over 27 years, Mr. Kim has held various financial roles in the pharmaceutical and banking industries. Prior to joining AVEO’s management team, he served as Associate Director, Business Planning & Analysis (Commercial) Oncology, Ophthalmology & New Launches for Sandoz Group AG (a former division of Novartis AG). During Mr. Kim’s time at Sandoz, he oversaw and supported finance matters for the oncology, base injectable and ophthalmology franchises, including new product launches within the U.S. retail space. Mr. Kim has also worked for the Federal Reserve Bank of New York, LG Electronics, CVS Pharmacy, Inc. (Express Scripts), Teva Pharmaceuticals Industries Ltd., Novartis AG, Amgen Inc. and a few other biotech companies.

Mr. Kim holds a Bachelor of Arts in Economics and Political Science from The State University of New York at Binghamton and a Bachelor of Science in Accountancy and Master of Business Administration from Saint Peter’s University.